GlaxoSmithKline commissioned XVIVO to create a mechanism of action animation for Theravance’s new class of antibiotic, Vibativ developed to stop serious MRSA infections in hospital settings. Vibativ works by preventing bacterial ribosomes from making proteins, which replicating bacteria require to effectively build new cell walls. Bacteria will run out of cell wall material in the replication process effectively killing them.
“XVIVO is top notch! I work with a lot of vendors on behalf of my clients and XVIVO exceeding my expectations every time. Not only was the work outstanding, the service was as well. Even when things got crazy, and they did several times, XVIVO delivered with a positive, can do it attitude – making my life and direct contact with the client much easier.”
Account Director, Palio Communications